期刊
CHEMICAL COMMUNICATIONS
卷 58, 期 14, 页码 2247-2258出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d1cc06355c
关键词
-
资金
- National Natural Science Foundation of China [22102188, 22025207]
- Innovation Research Community Science Fund of China [21821005]
- National Natural Science Fund BRICS STI Framework Programme [51861145304]
- Chinese Postdoctoral Science Foundation [2020M680674]
Peptide-based supramolecular PIT nanoagents have been shown to enhance the effect of photoimmunotherapy by utilizing multiple pathways and collaborative strategies to amplify the immune response.
Combinational photoimmunotherapy (PIT) is considered to be an ideal strategy for the treatment of highly recurrent and metastatic cancer, because it can ablate the primary tumor and provide in situ an autologous tumor vaccine to induce the host immune response, ultimately achieving the goal of controlling tumor growth and distal metastasis. Significant efforts have been devoted to enhancing the immune response caused by phototherapy-eliminated tumors. Recently, supramolecular PIT nanoagents based on precise peptide self-assembly design have been employed to improve the efficacy of photoimmunotherapy by utilizing the stability, targeting capability and flexibility of drugs, increasing tumor immunogenicity and realizing the synergistic amplification of immune effects through multiple pathways and collaborative strategy. This review summarizes peptide-based supramolecular PIT nanoagents for phototherapy-synergized cancer immunotherapy and its progress in enhancing the effect of photoimmunotherapy, especially focusing on the design of peptide-based PIT nanoagents, the progress of bioactive peptides combined photoimmunotherapy, and the synergistic immune-response mechanism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据